Crossject S.A. (74C)
FSX
Closed
Aug 25, 2026
Day's Range
1.4152 wk Range
1.36Overview - 74C - Crossject S.A.
Key Statistics
Valuation
Enterprise Value
92.41M
P/E (Trailing)
‪-7.44‬
Price / Sales (TTM)
‪32.86‬
EV / EBITDA
‪-8.67‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-629.28%‬
Return on Assets
‪-23.40%‬
Return on Equity
‪212.74%‬
Ownership
Shares Outstanding
52.18M
Float
51.16M
Held by Insiders
‪19.85%‬
Held by Institutions
‪0.40%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪1.54‬
200-Day Avg
‪1.88‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 74C - Crossject S.A.
Peers - 74C - Crossject S.A.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
- 74CFSXCrossject S.A.84.39MMarket Cap-10.04%52-week change-7.44P/E (Trailing)‪0.00%‬Profit Margin
- IUI1FSXIntuitive Surgical, Inc.115.92BMarket Cap-24.42%52-week change43.46P/E (Trailing)‪28.44%‬Profit Margin
- ESLFSXEssilorLuxottica75.02BMarket Cap-63.37%52-week change30.33P/E (Trailing)‪8.51%‬Profit Margin
- ESLCFSXEssilorLuxottica S.A. Unsponsored ADR73.99BMarket Cap-66.04%52-week change29.78P/E (Trailing)‪8.51%‬Profit Margin
- HYBFSXHOYA Corporation44.69BMarket Cap+16.46%52-week change33.13P/E (Trailing)‪27.17%‬Profit Margin
- BOXFSXBecton, Dickinson and Company44.57BMarket Cap-2.35%52-week change32.35P/E (Trailing)‪4.19%‬Profit Margin
- HYB0FSXHoya Corporation Sponsored ADR44.49BMarket Cap+17.29%52-week change32.67P/E (Trailing)‪27.17%‬Profit Margin
Profile Summary - 74C - Crossject S.A.
About
Crossject S.A. is a pharmaceutical company specializing in the development of needle-free, pre-filled delivery systems known as Zeneo injectors. Its primary function is to provide a pain-free, user-friendly alternative to traditional hypodermic injection methods, aiming to enhance patient compliance and accessibility.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
